Welcome to our dedicated page for Amedisys news (Ticker: AMED), a resource for investors and traders seeking the latest updates and insights on Amedisys stock.
Amedisys Inc. (NASDAQ: AMED) is a leading healthcare services company in the United States, specializing in delivering personalized home health, hospice, and high-acuity care services. Headquartered in Baton Rouge, LA, with an executive office in Nashville, TN, the company employs around 18,700 staff across 520 care centers in 37 states and the District of Columbia. Founded in 1982, Amedisys is dedicated to providing quality, clinically-distinctive care to more than 469,000 patients annually, with over 10.6 million visits each year.
Amedisys operates across four key segments: Home Health, Hospice, High Acuity Care, and Personal Care. The Home Health segment offers skilled nursing, therapy, and aid services directly in patients' homes, while the Hospice segment provides end-of-life care to terminally ill patients. The High Acuity Care segment delivers critical inpatient care elements at home, and the Personal Care segment, which was divested in March 2023, offered assistance with daily living activities.
Amedisys's commitment to high-quality care is underpinned by its comprehensive coordination with healthcare providers and personalized care plans tailored to each patient's unique needs. With a strong network involving more than 3,000 hospitals and 110,000 physicians nationwide, Amedisys is a trusted partner in post-acute care.
Recent notable achievements include a merger agreement with UnitedHealth Group, aimed at enhancing patient care through integrated services. Financially, Amedisys reported a net service revenue increase to $571.4 million for Q1 2024, reflecting a robust service demand despite divesting the Personal Care segment.
Additionally, Amedisys is actively involved in advancing healthcare technology. The company has partnered with Patient Choice Laboratories to incorporate advanced molecular testing, enhancing infection diagnosis and patient outcomes. This innovation underscores Amedisys’s commitment to leveraging cutting-edge technology to improve patient care.
For stakeholders, Amedisys remains a prominent figure in the home healthcare industry, constantly adapting and growing to meet the increasing needs of its patient population. The company's strategic partnerships and advancements in healthcare technology position it well for sustained growth and improved patient outcomes.
Amedisys, Inc. (NASDAQ: AMED) announced that its leadership team, including CEO Paul B. Kusserow, President Chris Gerard, and CFO Scott Ginn, will present at the Credit Suisse 30th Annual Virtual Healthcare Conference on November 9 at 12:10 p.m. Eastern.
Investors can access the live webcast via the company's investor relations website. Amedisys specializes in home health, hospice, personal care, and higher acuity services, serving over 418,000 patients annually across 38 states with a workforce of approximately 21,000 employees.
Amedisys, Inc. (NASDAQ: AMED) announced the acquisition of regulatory assets enabling the establishment of home health care centers in Charlotte and Raleigh, N.C. This expansion allows Amedisys to provide services to over 350,000 Medicare enrollees and 100,000 Medicare Advantage enrollees. The company will launch two new care centers in these markets, enhancing access to compassionate, high-quality care. Amedisys, a major provider in home health and hospice care in the U.S., operates 527 locations across 39 states.
Amedisys, Inc. (NASDAQ: AMED) will report its third quarter results for the period ending September 30, 2021, after market hours on November 2, 2021. An investor conference call to discuss these results is scheduled for November 3, 2021, at 11:00 a.m. ET. Participants can join the call by dialing (877) 524-8416 or (412) 902-1028. A replay will be available until December 3, 2021, via the same numbers. A live webcast will be accessible on Amedisys' Investor Relations website.
Henry Ford Health System has partnered with Contessa, an Amedisys company (NASDAQ: AMED), to introduce high-acuity home care services in Michigan. The new offerings include Hospital Care at Home, Skilled Nursing Care at Home, and Palliative Care at Home, aimed at delivering comprehensive patient care in a familiar environment. This initiative is expected to lower costs and improve patient outcomes, reducing readmission rates by 44% and hospital stays by 35%. Services will commence in December 2021 at Henry Ford Hospital in Detroit, with plans for future expansions.
Amedisys, Inc. (NASDAQ: AMED) announced on September 20, 2021, its definitive agreement to acquire regulatory assets enabling it to establish home health care centers in the Charlotte and Raleigh markets of North Carolina. The transaction, set to close on October 18, 2021, will allow Amedisys to expand its certified home health care services in Mecklenburg and Wake Counties, serving over 350,000 Medicare enrollees. This acquisition positions Amedisys to enhance its service area and patient care.
Amedisys, Inc. (NASDAQ: AMED) reported strong financial results for Q2 2021, achieving a net service revenue of $564.2 million, a significant increase from $485.0 million in 2020. Net income rose to $80.1 million compared to $34.7 million in the previous year. The company also announced the successful acquisition of Contessa Health, enhancing its home-based care delivery capabilities. Despite a solid performance, the Hospice segment faced challenges due to hiring difficulties. Updated guidance anticipates adjusted net service revenue between $2.241 billion and $2.259 billion for 2021.
Amedisys, Inc. (NASDAQ: AMED) has successfully acquired regulatory assets enabling it to conduct home health care operations in Westchester County, NY. The agreement grants Amedisys the right to operate certified home health care services in Westchester and the Bronx, with plans to establish a care center catering to approximately 375,000 Medicare and 165,000 Medicare Advantage enrollees. This expansion reinforces Amedisys's position as a significant player in the aging-in-place sector.
Amedisys, Inc. (NASDAQ: AMED) will report its second quarter results for the period ending June 30, 2021, on August 4, 2021. An investor conference call is scheduled for August 5, 2021, at 11:00 a.m. ET to discuss these results. Participants can call in using the numbers provided, and a replay will be available until September 5, 2021. Amedisys is a leading healthcare provider offering home health, hospice, and personal care, serving over 418,000 patients annually with approximately 21,000 employees across 514 care centers in 39 states and D.C.
Amedisys has completed its acquisition of Visiting Nurse Association (VNA), expanding its home health and hospice services in Omaha, Nebraska, and Council Bluffs, Iowa. This strategic move aims to enhance Amedisys' capacity to care for more patients by leveraging VNA's legacy. Amedisys will provide services through Amedisys Home Health and AseraCare Hospice, while VNA will continue its community-focused programs. The acquisition supports Amedisys' goal to deliver comprehensive care at home, reflecting its commitment to improving health services in these regions.
Amedisys has announced a definitive agreement to acquire Contessa Health, a leader in hospital-at-home and skilled nursing at home services. This strategic acquisition will enhance Amedisys's capabilities by adding advanced analytics and risk management, while significantly expanding its total addressable market from $44B to $73B. The deal positions Amedisys as the first major home health provider to operate in this high-acuity care space, reflecting an increasing trend for patients to receive care in familiar environments. The transaction is set to close in summer 2021, pending regulatory approvals.
FAQ
What is the current stock price of Amedisys (AMED)?
What is the market cap of Amedisys (AMED)?
What services does Amedisys Inc. provide?
Where is Amedisys Inc. headquartered?
How many employees does Amedisys have?
What is the scope of Amedisys's operations?
How many patients does Amedisys serve annually?
What recent merger has Amedisys entered into?
What recent technological advancement has Amedisys incorporated?
What was Amedisys's net service revenue for Q1 2024?
How does Amedisys coordinate patient care?
What was the Personal Care segment of Amedisys?
